Abstract
Purpose
Perioperative regional anesthesia with consecutive reduction of intra- and postoperative systemic opioid requirements in order to improve oncological result after cancer surgery has only been addressed by a few reports. This hypothesis has never been proved in esophageal cancer with a long-term follow-up of more than 5 years. Therefore, we addressed the impact on short- and long-term outcomes of epidural analgesia for esophagus cancer surgery.
Methods
All available records from patients who underwent esophageal cancer surgery from 1995 to 2005 were retrospectively analyzed. Short- and long-term outcome variables including opioid requirements, duration of ICU-stay, survival, and cancer recurrence were compared between patients with and patients without epidural analgesia for abdomino-right-thoracic esophagectomy.
Results
Overall, the analysis included 153 patients, 118 received epidural analgesia; in 35 patients, epidural analgesia was avoided. We found significantly increased postoperative median opioid consumption (10-day intravenous morphine equivalent 187 versus 104 mg) and duration of ICU hospitalization (10.1 vs. 5.9 days, p < 0.05) in the non-epidural group compared with the epidural group. However, there were no significant differences in cancer recurrence (23 % non-epidural group, 27 % epidural group), 1-year mortality (14 vs. 11 %), or 5-year survival (29 vs. 28 %) between the two patient groups.
Conclusions
The results of our study underline the well-known clinical benefits of epidural analgesia for esophagus surgery. However, we found no evidence that the further oncological outcome is determined or significantly influenced by the presence or absence of epidural analgesia.
Similar content being viewed by others
References
Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M (2010) Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110(6):1636–1643. doi:10.1213/ANE.0b013e3181de0ab6
Kawaraguchi Y, Horikawa YT, Murphy AN, Murray F, Miyanohara A, Ali SS, Head BP, Patel PM, Roth DM, Patel HH (2011) Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins. Anesthesiology 115(3):499–508. doi:10.1097/ALN.0b013e3182276d42
Forget P, Collet V, Lavand’homme P, De Kock M (2010) Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 27(3):233–240. doi:10.1097/EJA.0b013e32832d540e
Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ (2009) Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 103(5):685–690. doi:10.1093/bja/aep261
Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ (2011) Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene. Br J Anaesth 107(6):916–923. doi:10.1093/bja/aer259
Deegan CA, Murray D, Doran P, Moriarty DC, Sessler DI, Mascha E, Kavanagh BP, Buggy DJ (2010) Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med 35(6):490–495. doi:10.1097/AAP.0b013e3181ef4d05
Lordick F, Holscher AH, Haustermans K, Wittekind C (2013) Multimodal treatment of esophageal cancer. Langenbecks Arch Surg 398(2):177–187
Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, Bessler H (1996) Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg 82(3):492–497
Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno G, Ammatuna M, Panerai AE (2000) The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 90(6):1411–1414
Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, Guyre PM (1995) Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology 83(3):500–508
Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C (2000) Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res 10(2):165–169
Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105(4):660–664
Ali M, Winter DC, Hanly AM, O’Hagan C, Keaveny J, Broe P (2010) Prospective, randomized, controlled trial of thoracic epidural or patient-controlled opiate analgesia on perioperative quality of life. Br J Anaesth 104(3):292–297
Loubert C, Hinova A, Fernando R (2011) Update on modern neuraxial analgesia in labour: a review of the literature of the last 5 years. Anaesthesia 66(3):191–212
Grade M, Quintel M, Ghadimi BM (2011) Standard perioperative management in gastrointestinal surgery. Langenbecks Arch Surg 396(5):591–606
Charrios T, Lindsay M, Bruera E (1998) Utilizing a morphine equivalent daily dose for comparison of opioid use in two palliative care units in Canada. J Palliat Care 14(3):117
Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E (2001) Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing. J Pain Symptom Manag 22(2):672–687
Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ (2014) Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery. Acta Anaesthesiol Scand 2(10):12255
Lagergren J, Lagergren P (2013) Recent developments in esophageal adenocarcinoma. CA Cancer J Clin 63(4):232–248
Freise H, Van Aken HK (2011) Risks and benefits of thoracic epidural anaesthesia. Br J Anaesth 107(6):859–868
Weijs TJ, Ruurda JP, Nieuwenhuijzen GA, van Hillegersberg R (2013) Luyer MD strategies to reduce pulmonary complications after esophagectomy. World J Gastroenterol 19(39):6509–6514. doi:10.3748/wjg.v19.i39.6509
McKevith JM, Pennefather SH (2010) Respiratory complications after oesophageal surgery. Curr Opin Anaesthesiol 23(1):34–40
Cense HA, Lagarde SM, de Jong K, Omloo JM, Busch OR, Henny Ch P, van Lanschot JJ (2006) Association of no epidural analgesia with postoperative morbidity and mortality after transthoracic esophageal cancer resection. J Am Coll Surg 202(3):395–400. doi:10.1016/j.jamcollsurg.2005.11.023
Beck DH, McQuillan P, Smith GB (2002) Waiting for the break of dawn? The effects of discharge time, discharge TISS scores and discharge facility on hospital mortality after intensive care. Intensive Care Med 28(9):1287–1293
Gong L, Dong C, Ouyang W, Qin Q (2013) Regulatory T cells: a possible promising approach to cancer recurrence induced by morphine. Med Hypotheses 80(3):308–310
Singleton PA, Moss J (2010) Effect of perioperative opioids on cancer recurrence: a hypothesis. Future Oncol 6(8):1237–1242
Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI (2011) Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 29 (342)
Gottschalk A, Ford JG, Regelin CC, You J, Mascha EJ, Sessler DI, Durieux ME, Nemergut EC (2010) Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology 113(1):27–34. doi:10.1097/ALN.0b013e3181de6d0d
Holler JP, Ahlbrandt J, Burkhardt E, Gruss M, Rohrig R, Knapheide J, Hecker A, Padberg W, Weigand MA (2013) Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): an analysis of a cancer registry. Ann Surg 258(6):989–993. doi:10.1097/SLA.0b013e3182915f61
Roiss M, Schiffmann J, Tennstedt P, Kessler T, Blanc I, Goetz A, Schlomm T, Graefen M, Reuter DA (2014) Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter? Eur J Surg Oncol. doi:10.1016/j.ejso.2014.02.223
Melis M, McLoughlin JM, Dean EM, Siegel EM, Weber JM, Shah N, Kelley ST, Karl RC (2009) Correlations between neoadjuvant treatment, anemia, and perioperative complications in patients undergoing esophagectomy for cancer. J Surg Res 153(1):114–120. doi:10.1016/j.jss.2008.06.005
de Oliveira GS Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Regional Anesth Pain Med 36(3):271–277
Feng JF, Huang Y, Lu WS, Chen QX (2013) Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Langenbecks Arch Surg 398(8):1115–1122
Ummenhofer WC, Arends RH, Shen DD, Bernards CM (2000) Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil. Anesthesiology 92(3):739–753
Authors’ contributions
Joachim Schmidt and Sebastian Heinrich designed the study. Data acquisition was performed by Susanne Merkel and Katrin Janitz. Sebastian Heinrich, Joachim Schmidt, and Peter Klein analyzed and interpreted the data. Writing and drafting of manuscript was in responsibility of the corresponding author Sebastian Heinrich. Joachim Schmidt and Peter Klein critically revised the manuscript.
Conflicts of interest
None of the authors has conflicts of interest or any relationship to products, companies, or procedures named in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heinrich, S., Janitz, K., Merkel, S. et al. Short- and long term effects of epidural analgesia on morbidity and mortality of esophageal cancer surgery. Langenbecks Arch Surg 400, 19–26 (2015). https://doi.org/10.1007/s00423-014-1248-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-014-1248-9